Enteric duplication in children: clinical presentation and outcome

Share this Article

Singapore Med J 2013; 54(6): 343-346; http://dx.doi.org/10.11622/smedj.2013129
Enteric duplication in children: clinical presentation and outcome

Rasool N, Safdar CA, Ahmad A, Kanwal S
Correspondence: Major Naima Rasool, dr_naima_r@yahoo.com

ABSTRACT
Introduction Enteric duplication (ED) is an anomaly with varied presentations and possible involvement of the alimentary tract. Once diagnosed, resection of the lesion and the involved part of the gut is usually required. The aim of this study was to evaluate the clinical presentations, diagnostic investigations, management and outcomes of patients with ED.
Methods This was a descriptive case study conducted at the Department of Paediatric Surgery, Military Hospital, Rawalpindi, Pakistan, from January 2005 to January 2011. The medical records of all patients diagnosed with ED were retrospectively analysed with respect to age, presentation, investigations, site and type of lesion, surgical procedures, histological findings and complications.
Results A total of nine patients were managed during the study period. The patients’ ages ranged from three months to five years. Four out of nine EDs were rectal duplications. Three EDs were of the cystic type, five were of the tubular type and one was a complex mixed anomaly. Patients presented with varied symptoms, with the two most common being the presence of an abdominal mass and bleeding per rectum. Diagnosis was mainly achieved based on magnetic resonance imaging and computed tomography, although Meckel’s scan provided accurate diagnosis in three of the nine patients. All the cysts were resected without any major complications, and patients were event-free during the five-year follow-up.
Conclusion EDs should be kept in mind when examining patients with an abdominal mass and bleeding per rectum. Meckel’s scan can provide accurate diagnosis of EDs with bleeding. Prompt diagnosis and management results in satisfactory outcomes.

Keywords: gastrointestinal diseases, gastrointestinal haemorrhage
Singapore Med J 2013; 54(6): 343-346; http://dx.doi.org/10.11622/smedj.2013129

REFERENCES

1. Patel MP, Meisheri IV, Waingankar VS, et al. Duplication cyst of the pylorus- a rare cause of gastric outlet obstruction in the newborn. J Postgrad Med 1997; 43:43-5.
 
2. Lipsett J, Sparnon AL, Byard RW. Embryogenesis of enterocystomas-enteric duplication cysts of the tongue. Oral Surg Oral Med Oral Pathol 1993; 75:626-30.
http://dx.doi.org/10.1016/0030-4220(93)90238-Y
 
3. Olajide AR, Yisau AA, Abdulraseed NA, et al. Gastrointestinal duplications: Experience in seven children and a review of the literature. Saudi J Gastroenterol 2010; 16:105-9.
http://dx.doi.org/10.4103/1319-3767.61237
 
4. Stringer MD, Spitz L, Abel R, et al. Management of alimentary tract duplication in children. Br J Surg 1995; 82:74-8.
http://dx.doi.org/10.1002/bjs.1800820126
 
5. Karnak I, Ocal T, Senocak ME, Tanyel FC, Büyükpamukçu N. Alimentary tract duplications in children: report of 26 years' experience. Turk J Pediatr 2000; 42:118-25.
 
6. Okamoto T, Takamizawa S, Yokoi A, Satoh S, Nishijima E. Completely isolated alimentary tract duplication in a neonate. Pediatr Surg Int 2008; 24:1145-7.
http://dx.doi.org/10.1007/s00383-008-2220-y
 
7. Ildstad ST, Tollerud DJ, Weiss RG, et al. Duplications of the alimentary tract. Clinical characteristics, preferred treatment, and associated malformations. Ann Surg 1988; 208:184-9.
http://dx.doi.org/10.1097/00000658-198808000-00009
 
8. Schalamon J, Schleef J, Höllwarth ME. Experience with gastro-intestinal duplications in childhood. Langenbecks Arch Surg 2000; 385:402-5.
http://dx.doi.org/10.1007/s004230000170
 
9. Ijaz L, Husnain M, Malik SI, Mirza B. Cecal duplication cyst presenting as acute intestinal obstruction in a neonate. APSP J Case Rep 2011; 2:11.
 
10. Cheng G, Soboleski D, Daneman A, Poenaru D, Hurlbut D. Sonographic pitfalls in the diagnosis of enteric duplication cysts. AJR Am J Roentgenol 2005; 184:521-5.
http://dx.doi.org/10.2214/ajr.184.2.01840521
 
11. Gümü? M, Kapan M, Gümü? H, Onder A, Girgin S. Unusual noncommunicating isolated enteric duplication cyst in adults. Gastroenterol Res Pract 2011; 2011:323919.
 
12.Holcomb GW 3rd, Gheissari A, O'Neill JA Jr, Shorter NA, Bishop HC. Surgical management of alimentary tract duplications. Ann Surg 1989; 209:167-74.
http://dx.doi.org/10.1097/00000658-198902000-00006
 
13. Iyer CP, Mahour GH. Duplications of the alimentary tract in infants and children. J Pediatr Surg 1995; 30:1267-70.
http://dx.doi.org/10.1016/0022-3468(95)90482-4
 
14. Ravitch MM. Duplications of the gastrointestinal tract. In: Welch KJ, Randolph JG, Ravitch MM, Mustard WT, eds. Pediatric Surgery, 4th ed. Chicago: Years book publishers, 1986; 914-5.
 
15. Wrenn EL. Alimentary tract duplications. In: Ashcraft KW, Holder TM, eds. Pediatric Surgery, 2nd ed. Philadelphia: WB Saunders Company, 1993; 421-34.
 
16. Sasaki T, Shimura H, Ryu S, Matsuo K, Ikeda S . Laparoscopic treatment of a gastric duplication cyst: report of a case. Int Surg 2003; 88:68-71.
 
17. Yang MC, Duh YC, Lai HS, et al. Alimentary tract duplications. J Formos Med Assoc 1996; 95:406-9.
 
18. Sato T, Oyamada M, Chiba H, et al. Ileal duplication cyst associated with heterotopic pancreas: report of a case and literature review. Acta Pathol Jpn 1993; 43:597-602.

Pattern of psychiatric morbidity among theft offenders remanded or referred for psychiatric evaluation and factors associated with reoffence

Share this Article

Singapore Med J 2013; 54(6): 339-342; http://dx.doi.org/10.11622/smedj.2013128
Pattern of psychiatric morbidity among theft offenders remanded or referred for psychiatric evaluation and factors associated with reoffence

Chan LG, Bharat S, Dani SK
Correspondence: Dr Lai Gwen Chan, lai_gwen_chan@ttsh.com.sg

ABSTRACT
Introduction In Singapore, theft and related crimes constitute more than 50% of all reported crime, and are the most common offences committed by accused persons remanded to the Institute of Mental Health (IMH), Singapore. There is a need for better understanding of the forensic psychiatric aspects of such offenders. This study aimed to determine the prevalence of psychiatric disorders among theft offenders remanded or referred for forensic assessment in 2010, compare the differences between first-time and repeat theft offenders, and identify the factors associated with reoffence. 
Methods Forensic evaluations of inpatient and outpatient theft offenders that were conducted at IMH in the year 2010 were retrieved and reviewed. The sociodemographic and clinical data of first-time and repeat theft offenders were collected and compared using Student’s t-test and chi-square test for continuous and categorical variables, respectively. Multivariate regression was used to identify the factors that were predictive of repeat offence. 
Results Overall, 10% of offenders had no mental illness. Substance use disorders, mood disorders and psychotic disorders were the most common diagnoses. Psychotic disorders were significantly less common in repeat offenders. Repeat offenders also tended to have a history of conduct problems in childhood. Noncompliance with psychiatric treatment was positively associated with repeat offence, while psychotic disorders were negatively associated. 
Conclusion The pattern of psychiatric morbidity among theft offenders in Singapore has changed over the last ten years. Kleptomania remains rare. Significant differences between first-time and repeat offenders have implications on the treatment, follow-up and rehabilitation of theft offenders in Singapore.

Keywords: forensic psychiatry, kleptomania, recidivism, remand, theft
Singapore Med J 2013; 54(6): 339-342; http://dx.doi.org/10.11622/smedj.2013128

REFERENCES

1. Singapore Police Force. Crime Situation for 2010 and 2011. In: Singapore Police Force [online]. Available at: http://www.spf.gov.sg/stats/stats2010_overalldown.htm. Accessed August 8, 2012.
 
2. Lim LE, Chan KL, Tan LL, et al. A review of offenders remanded in a State Psychiatric Hospital. Singapore Med J 2000; 41:114-7.
 
3. High Court of Singapore. Public Prosecutor vs L.Y. Goh. In: IpsofactoJ.com [online]. Available at: http://www.ipsofactoj.com/highcourt/2008/Part01/hct2008(01)-015.htm. Accessed August 14, 2012.
 
4. Woo BS, Parker G, Loh MI. A comparison of male and female theft offenders remanded to a state psychiatric hospital. Singapore Med J 2001; 42:304-7.
 
5. Bowden P. Men remanded into custody for medical reports: the outcome of the treatment recommendation. Br J Psychiatry 1978; 133:332-8.
http://dx.doi.org/10.1192/bjp.133.4.332
 
6. Lau BW. The medical recommendation for psychiatric remands into prison--the Hong Kong scene. Med Sci Law 1981; 21:57-65.
 
7. Smith J, Grant F, Brinded P. Schizophrenics remanded to the Forensic Psychiatric Institute of British Columbia, 1975-1990. Med Sci Law 1994; 34:221-6.
 
8. Lamontagne Y, Carpentier N, Hetu C, et al. Shoplifting and mental illness. Can J Psychiatry 1994; 39:300-2.
 
9. Blanco C, Grant J, Petry NM, et al. Prevalence and correlates of shoplifting in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Am J Psychiatry 2008; 165:905-13.
http://dx.doi.org/10.1176/appi.ajp.2008.07101660
 
10. Sansone RA, Chang J, Jewell B, Sellbom M. Relationships among Shoplifting, Compulsive Buying, and Borderline Personality Symptomatology. Innov Clin Neurosci 2011; 8:10-1.
 
11. Cheng RS, Lin C, Fok ML, Leung CM. Shoplifting in the mentally ill: the role of bipolar affective disorder and mental retardation. Med Sci Law 2005; 45:317-20.
http://dx.doi.org/10.1258/rsmmsl.45.4.317
 
12. Kua EH, Chee C. Shoplifting--badness, madness or sadness. Singapore Med J. 1999; 40:443-4.
 
13. Gudjonsson GH. The significance of depression in the mechanism of 'compulsive' shoplifting. Med Sci Law 1987; 27:171-6.

Management of ruptured intracranial aneurysms in the post-ISAT era: outcome of surgical clipping versus endovascular coiling in a Singapore tertiary institution

Share this Article

Singapore Med J 2013; 54(6): 332-338; http://dx.doi.org/10.11622/smedj.2013127
Management of ruptured intracranial aneurysms in the post-ISAT era: outcome of surgical clipping versus endovascular coiling in a Singapore tertiary institution

Koh KM, Ng Z, Low SY, Chua HZ, Chou N, Low SW, Yeo TT
Correspondence: Dr Sharon Low Yin Yee, sharon.yy.low@gmail.com

ABSTRACT
Introduction The results of the International Subarachnoid Aneurysm Trial (ISAT) in 2002 have significantly influenced the management of ruptured intracranial aneurysms. There is now an established shift worldwide toward endovascular coiling as the initial treatment of choice. We assessed the outcomes of patients admitted to our institution for aneurysmal subarachnoid haemorrhage (SAH), comparing the outcomes of patients (World Federation of Neurosurgical Societies [WFNS] grades 1–3) who underwent surgical clipping versus those who underwent endovascular coiling.
Methods We retrospectively reviewed patients admitted to the National University Hospital for SAH secondary to ruptured intracranial aneurysm in 2005–2009. Patients were divided into two groups – clipping and coiling. Data on individual demographics, comorbidities, Fisher grading and Glasgow Outcome Scale scores were collected for the two groups and subjected to relevant statistical analyses.
Results Of the 133 patients admitted for nontraumatic SAH, 89 had ruptured aneurysms. Among the 56 patients classified as WFNS grades 1–3, 23 underwent coiling while the remaining 33 underwent clipping. A significant association was found between Fisher grade and the likelihood of developing hydrocephalus in these patients.
Conclusion Although we acknowledge the presence of management bias in our institution, our findings were similar to those of the ISAT trial. Upon correlation between our results and current evidence-based findings, our findings show that clipping provides similar long-term outcomes as endovascular coiling. In the event that an aneurysm is deemed unsuitable for coiling, clipping remains an effective option.

Keywords: endovascular coiling, intracranial aneurysm, subarachnoid haemorrhage, surgical clipping
Singapore Med J 2013; 54(6): 332-338; http://dx.doi.org/10.11622/smedj.2013127

REFERENCES

1. Dupont SA, Wijdicks EF, Lanzino G, Rabinstein AA. Aneurysmal subarachnoid hemorrhage: an overview for the practicing neurologist. Semin Neurol 2010; 30:545-54.
http://dx.doi.org/10.1055/s-0030-1268862
 
2. Penn DL, Komortar RJ, Sander Connolly E. Hemodynamic mechanisms underlying cerebral aneurysm pathogenesis. J Clin Neurosci 2011; 18:1435-8.
http://dx.doi.org/10.1016/j.jocn.2011.05.001
 
3. Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002; 360:1267-74.
http://dx.doi.org/10.1016/S0140-6736(02)11314-6
 
4. McDougall CG, Spetzler RF, Zabramski JM, et al. The Barrow Ruptured Aneurysm Trial. J Neurosurg 2012; 116:135-44.
http://dx.doi.org/10.3171/2011.8.JNS101767
 
5. Molyneux AJ, Kerr RS, Birks J, et al. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol 2009; 8:427-33.
http://dx.doi.org/10.1016/S1474-4422(09)70080-8
 
6. Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurysmal subarachnoid haemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25:2315-28.
http://dx.doi.org/10.1161/01.STR.25.11.2315
 
7. Wardlaw JM, White PM. The detection and management of unruptured intracranial aneurysms. Brain 2000; 123:205-21.
http://dx.doi.org/10.1093/brain/123.2.205
 
8. Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997; 28:660-64.
http://dx.doi.org/10.1161/01.STR.28.3.660
 
9. Hoh BL, Kleinhenz DT, Chi YY, Mocco J, Barker FG 2nd. Incidence of ventricular shunt placement for hydrocephalus with clipping versus coiling for ruptured and unruptured cerebral aneurysms in the Nationwide Inpatient Sample database: 2002 to 2007. World Neurosurg 2011; 76:548-54.
http://dx.doi.org/10.1016/j.wneu.2011.05.054
 
10. Linn FH, Rinkel GJ, Algra A, van Gijn J. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke 1996; 27:625-9.
http://dx.doi.org/10.1161/01.STR.27.4.625
 
11. van Dijk JM, Groen RJ, Ter Laan M, Jeltema JR, Mooij JJ, Metzemaekers JD. Surgical clipping as the preferred treatment for aneurysms of the middle cerebral artery. Acta Neurochir (Wien) 2011; 153:2111-7.
http://dx.doi.org/10.1007/s00701-011-1139-6
 
12. Tidswell P, Dias PS, Sagar HJ, Mayes AR, Battersby RD. Cognitive outcome after aneurysm rupture: relationship to aneurysm site and perioperative complications. Neurology 1995; 45:875-82.
http://dx.doi.org/10.1212/WNL.45.5.876
 
13. Nam KH, Hamm IS, Kang DH, Park J, Kim YS. Risk of shunt dependent hydrocephalus after treatment of ruptured intracranial aneurysms: surgical clipping versus endovascular coiling according to fisher grading system. J Korean Neurosurg Soc 2010; 48:313-8.
http://dx.doi.org/10.3340/jkns.2010.48.4.313
 
14. de Oliveira JG, Beck J, Setzer M, et al. Risk of shunt-dependent hydrocephalus after occlusion of ruptured intracranial aneurysms by surgical clipping or endovascular coiling: a single-institution series andmeta-analysis. Neurosurgery 2007; 61:924-33.
http://dx.doi.org/10.1227/01.neu.0000303188.72425.24
 
15. Taha MM, Nakahara I, Higashi T, et al. Endovascular embolization vs surgical clipping in treatment of cerebral aneurysms: morbidity and mortality with short-term outcome. Surg Neurol 2006; 66:277-84.
http://dx.doi.org/10.1016/j.surneu.2005.12.031
 
16. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6:1-9.
http://dx.doi.org/10.1227/00006123-198001000-00001
 
17. Dorai Z, Hynan LS, Kopitnik TA, Samson D. Factors related to hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003; 52:763-9.
http://dx.doi.org/10.1227/01.NEU.0000053222.74852.2D
 
18. Ellington E, Margolis G. Block of arachnoid villus by subarachnoid hemorrhage. J Neurosurg 1969; 30:651-7.
http://dx.doi.org/10.3171/jns.1969.30.6.0651
 
19. Brydon H, Bayston R, Hayward R, Harkness W. The effect of protein and blood cells on the flow-pressure characteristics of shunts. Neurosurgery 1996; 38:498-505.
 
20. Al-Tamimi YZ, Ahmad M, May SE, et al. A comparison of the outcome of aneurysmal subarachnoid haemorrhage before and after the introduction of an endovascular service. J Clin Neurosci 2010; 17:1391-4.
http://dx.doi.org/10.1016/j.jocn.2010.03.024
 
21. Naidech AM, Janjua N, Kreiter KT, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol 2005; 62:410-6.
http://dx.doi.org/10.1001/archneur.62.3.410
 
22. Qureshi AI, Janardhan V, Hanel RA, Lanzino G. Comparison of endovascular and surgical treatments for intracranial aneurysms: an evidence-based review. Lancet Neurol 2007; 6:816-25.
http://dx.doi.org/10.1016/S1474-4422(07)70217-X

Is semen polymorphonuclear leucocytes count a good predictor of male genital tract infection?

Share this Article

Singapore Med J 2013; 54(6): 328-331; http://dx.doi.org/10.11622/smedj.2013126
Is semen polymorphonuclear leucocytes count a good predictor of male genital tract infection?

Chen L, Yu SL, Rajesh H
Correspondence: Dr Lihang Chen, lihang_chen@126.com

ABSTRACT
Introduction This study aims to evaluate whether an increased polymorphonuclear leucocyte (PMN) count in semen is a good predictor of male genital tract infection, which is detected by semen culture.
Methods A retrospective cross-sectional study examining the semen of 388 men was conducted at the in vitro fertilisation centre of a tertiary hospital. We compared the culture results of 109 men with increased semen PMN count against those of 279 men with normal semen PMN count.
Results There was no significant difference in the percentage of positive cultures between men with increased PMN count in their semen and those without PMN count elevation (original sensitivity 20.8%, specificity 70.3%; p = 0.1289). The overall percentage of positive semen cultures among all 388 patients was 18.6%.
Conclusion Based on the positive cultures of significant organisms in the semen of our cohort, an increased semen PMN count is not a good predictor of genital tract infection in men.

Keywords: bacteriospermia, infertility, male genital tract infection, polymorphonuclear leucocytes, sperm analysis
Singapore Med J 2013; 54(6): 328-331; http://dx.doi.org/10.11622/smedj.2013126

REFERENCES

1. Cooper TG, Aitken J, Auger J, et al, eds. WHO laboratory manual for the examination and processing of human semen. 5th ed. Switzerland: World Health Organization, 2010.
 
2. Bezold G, Politch JA, Kiviat NB, et al. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril 2007; 87:1087-97.
http://dx.doi.org/10.1016/j.fertnstert.2006.08.109
 
3. Cumming JA, Carrell DT. Utility of reflexive semen cultures for detecting bacterial infections in patients with infertility and leukocytospermia. Fertil Steril 2009; 91 (4 Suppl):1486-8.
http://dx.doi.org/10.1016/j.fertnstert.2008.07.1756
 
4. Lackner JE, Herwig R, Schmidbauer J, et al. Correlation of leukocytospermia with clinical infection and the positive effect of antiinflammatory treatment on semen quality. Fertil Steril 2006; 86:601-5.
http://dx.doi.org/10.1016/j.fertnstert.2006.01.032
 
5. Cottell E, Harrison RF, McCaffrey M, et al. Are seminal fluid microorganisms of significance or merely contaminants? Fertil Steril 2000; 74:465-70.
http://dx.doi.org/10.1016/S0015-0282(00)00709-3
 
6. Lackner J, Schatzl G, Horvath S, Kratzik C, Marberger M. Value of counting white blood cells (WBC) in semen samples to predict the presence of bacteria. Eur Urol 2006; 49:148-52; discussion 152-3.
http://dx.doi.org/10.1016/j.eururo.2005.08.017
 
7. Gdoura R, Kchaou W, Znazen A, et al. Screening for bacterial pathogens in semen samples from infertile men with and without leukocytospermia. Andrologia 2008; 40:209-18.
http://dx.doi.org/10.1111/j.1439-0272.2008.00845.x
 
8. Aitken RJ, Baker HW, Barratt CL, et al, eds. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th ed. Cambridge, United Kingdom: World Health Organization, 1999.
 
9. Schaeffer AJ, Knauss JS, Landis JR, et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002; 168:1048-53.
http://dx.doi.org/10.1016/S0022-5347(05)64572-7
 
10. Berger RE, Karp LE, Williamson RA, et al. The relationship of pyospermia and seminal fluid bacteriology to sperm function as reflected in the sperm penetration assay. Fertil Steril 1982; 37:557-64.
 
11. Rodin DM, Larone D, Goldstein M. Relationship between semen cultures, leukospermia, and semen analysis in men undergoing fertility evaluation. Fertil Steril 2003; 79 Suppl 3:1555-8.
http://dx.doi.org/10.1016/S0015-0282(03)00340-6
 
12. Eggert-Kruse W, Probst S, Rohr G, Aufenanger J, Runnebaum B. Screening for subclinical inflammation in ejaculates. Fertil Steril 1995; 64:1012-22.
 
13. Eggert-Kruse W, Zimmermann K, Geissler W, et al. Clinical relevance of polymorphonuclear (PMN-) elastase determination in semen and serum during infertility investigation. Int J Androl 2009; 32:317-29.
http://dx.doi.org/10.1111/j.1365-2605.2007.00852.x
 
14. Cardoso EM, Santoianni JE, De Paulis AN, et al. Improvement of semen quality in infected asymptomatic infertile male after bacteriological cure. Medicina (B Aires) 1998; 58:160-4.
 
15. Virecoulon F, Wallet F, Fruchart-Flamenbaum A, et al. Bacterial flora of the low male genital tract in patients consulting for infertility. Andrologia 2005; 37:160-5.
http://dx.doi.org/10.1111/j.1439-0272.2005.00673.x
 
16. Kiessling AA, Lamparelli N, Yin HZ, Seibel MM, Eyre RC. Semen leukocytes: friends or foes? Fertil Steril 1995; 64:196-8.
 
17. Willén M, Holst E, Myhre EB, Olsson AM. The bacterial flora of the genitourinary tract in healthy fertile men. Scand J Urol Nephrol 1996; 30:387-93.
http://dx.doi.org/10.3109/00365599609181315
 
18. Zheng J, Yu SY, Jia DS, et al. [Ureaplasma urealyticum infection in the genital tract reduces seminal quality in infertile men]. Zhonghua Nan Ke Xue 2008; 14:507-12. Chinese.
 
19. Reinhardt A, Haidl G, Schill WB. Granulocyte elastase indicates silent male genital tract inflammation and appropriate anti-inflammatory treatment. Andrologia 1997; 29:187-92.
http://dx.doi.org/10.1111/j.1439-0272.1997.tb00315.x
 
20. Kopa Z, Wenzel J, Papp GK, Haidl G. Role of granulocyte elastase and interleukin-6 in the diagnosis of male genital tract inflammation. Andrologia 2005; 37:188-94.
http://dx.doi.org/10.1111/j.1439-0272.2005.00676.x

Effect of testosterone propionate on hippocampal pyramidal neuron number in female rats

Share this Article

Singapore Med J 2013; 54(6): 315-320; http://dx.doi.org/10.11622/smedj.2013124
Effect of testosterone propionate on hippocampal pyramidal neuron number in female rats

Candemir M, Semiz S, Yonguc GN, Ozdemir MB, Abban-Mete G, Adiguzel E
Correspondence: Dr Esat Adiguzel, esatadiguzel@yahoo.com

ABSTRACT
Introduction The hippocampus is an important region of the brain that regulates cognitive and emotional functions. In this study, we examined the impact of perinatal administration of testosterone propionate (TP) on the number of pyramidal neurons in the CA1 and CA3 regions of the hippocampi of female rats.
Methods Five groups of rats were used in this study. Three groups of female rats were administered TP in either both the prenatal and the postnatal periods (Group 1), only the prenatal period (Group 2) or only the postnatal period (Group 3). The other two groups of rats included control females (Group 4) and control males (Group 5). The rats were sacrificed on postnatal Day 120 and their brains were analysed for hippocampal pyramidal neuron number using stereological methods.
Results Control male rats (Group 5; p = 0.043) and TP-treated female rats in Groups 1 (p = 0.012) and 2 (p = 0.037), but not Group 3 (p > 0.05), had a significantly higher number of pyramidal neurons than control female rats (Group 4). The rats in Group 1 had the highest number of pyramidal neurons among the female rats.
Conclusion Perinatal TP treatment has an augmenting effect on the number of pyramidal neurons in the hippocampi of female rats. We also found gender-based differences in the hippocampi of male and female rats, with a higher number of pyramidal neurons seen in male rats. Continuous TP administration during the prenatal and postnatal periods is more effective than administration only in the prenatal or postnatal period.

Keywords: androgens, female, perinatal, rat, stereology
Singapore Med J 2013; 54(6): 315-320; http://dx.doi.org/10.11622/smedj.2013124

REFERENCES

1. McCarthy MM, Konkle AT. When is a sex difference not a sex difference? Front Neuroendocrinol 2005; 26:85-102.
http://dx.doi.org/10.1016/j.yfrne.2005.06.001
 
2. Hrabovszky Z, Hutson JM. Androgen imprinting of the brain in animal models and humans with intersex disorders: review and recommendations. J Urol 2002; 168:2142-8.
http://dx.doi.org/10.1016/S0022-5347(05)64338-8
 
3. Isgor C, Sengelaub DR. Prenatal gonadal steroids affect adult spatial behavior, CA1 and CA3 pyramidal cell morphology in rats. Horm Behav 1998; 34:183-98.
http://dx.doi.org/10.1006/hbeh.1998.1477
 
4. Wolf CJ, Hotchkiss A, Ostby JS, LeBlanc GA, Gray LE Jr. Effects of prenatal testosterone propionate on the sexual development of male and female rats: a dose-response study. Toxicol Sci 2002; 65:71-86.
http://dx.doi.org/10.1093/toxsci/65.1.71
 
5. Papez JW. Visceral brain, its components parts and their connections. J Nerv Ment Dis 1958; 126:40-56.
http://dx.doi.org/10.1097/00005053-195801000-00005
 
6. Woodson JC, Balleine BW, Gorski RA. Sexual experience interacts with steroid exposure to shape the partner preferences of rats. Horm Behav 2002; 42:148-57.
http://dx.doi.org/10.1006/hbeh.2002.1816
 
7. Isgor C, Sengelaub DR. Effects of neonatal gonadal steroids on adult CA3 pyramidal neuron dendritic morphology and spatial memory in rats. J Neurobiol 2003; 55:179-90.
http://dx.doi.org/10.1002/neu.10200
 
8. Zhang JM, Konkle AT, Zup SL, McCarthy MM. Impact of sex and hormones on new cells in the developing rat hippocampus: a novel source of sex dimorphism? Eur J Neurosci 2008; 27:791-800.
http://dx.doi.org/10.1111/j.1460-9568.2008.06073.x
 
9. Xiao L, Jordan CL. Sex differences, laterality, and hormonal regulation of androgen receptor immunoreactivity in rat hippocampus. Horm Behav 2002; 42:327-36.
http://dx.doi.org/10.1006/hbeh.2002.1822
 
10.West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991; 231:482-97.
http://dx.doi.org/10.1002/ar.1092310411
 
11. Gundersen HJ, Bagger P, Bendtsen TF, et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988; 96:857-81.
http://dx.doi.org/10.1111/j.1699-0463.1988.tb00954.x
 
12. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 6th ed. USA: Academic Press, Elsevier, 2007.
 
13. Paxinos G. Hippocampal formation. In: Paxinos G, ed. The Rat Nervous System. 3rd ed. USA: Academic Press, Elsevier, 2004: 637-87.
 
14. Hosseini-Sharifabad M, Nyengaard JR. Design-based estimation of neuronal number and individual neuronal volume in the rat hippocampus. J Neurosci Methods 2007; 162:206-14.
http://dx.doi.org/10.1016/j.jneumeth.2007.01.009
 
15. Demissie M, Lazic M, Foecking EM, et al. Transient prenatal androgen exposure produces metabolic syndrome in adult female rats. Am J Physiol Endocrinol Metab 2008; 295:262-8.
http://dx.doi.org/10.1152/ajpendo.90208.2008
 
16. Hilton GD, Nu-ez JL, McCarthy MM. Sex differences in response to kainic acid and estradiol in the hippocampus of newborn rats. Neuroscience 2003; 116:383-91.
http://dx.doi.org/10.1016/S0306-4522(02)00716-9
 
17. Madeira MD, Sousa N, Lima-Andrade MT, et al. Selective vulnerability of the hippocampal pyramidal neurons to hypothyroidism in male and female rats. J Comp Neurol 1992; 322:501-18.
http://dx.doi.org/10.1002/cne.903220405
 
18. Wimer RE, Wimer C. Three sex dimorphisms in the granule cell layer of the hippocampus in house mice. Brain Res 1985; 328:105-9.
http://dx.doi.org/10.1016/0006-8993(85)91328-9
 
19. Guillery RW, Herrup K. Quantification without pontification: choosing a method for counting objects in sectioned tissues. J Comp Neurol 1997; 386:2-7.
http://dx.doi.org/10.1002/(SICI)1096-9861(19970915)386:1<2::AID-CNE2>3.0.CO;2-6

Psychometric properties of the Iranian version of the Pediatric Quality of Life InventoryTM Short Form 15 Generic Core Scales

Share this Article

Singapore Med J 2013; 54(6): 309-314; http://dx.doi.org/10.11622/smedj.2013123
Psychometric properties of the Iranian version of the Pediatric Quality of Life InventoryTM Short Form 15 Generic Core Scales

Pakpour AH
Correspondence: Dr Amir H Pakpour, Pakpour_Amir@yahoo.com

ABSTRACT
Introduction The objective of this study was to assess the feasibility, reliability and validity of the Iranian version of the Pediatric Quality of Life Inventory™ 4.0 Short Form 15 Generic Core Scales (PedsQL™ 4.0 SF15) in a sample of Iranian schoolchildren and children with chronic health conditions.
Methods A total of 1236 schoolchildren and 1183 parents of schoolchildren participated, and 52 children with chronic health conditions and their parents were recruited from an outpatient clinic. Feasibility, internal consistency reliability, test-retest reliability, known-groups discriminant validity and construct validity of the PedsQL™ 4.0 SF15 were determined.
Results The Iranian version of PedsQL™ 4.0 SF15 evidenced minimal missing responses for child self-report and parent proxy-report (0.4% and 0.6%, respectively), generally demonstrated no significant floor or ceiling effects, and achieved acceptable internal consistency reliability for the Total Scale Score (α = 0.82 child self-report, 0.84 parent proxy-report) and acceptable test-retest reliability. Schoolchildren and their parents reported significantly higher PedsQL™ 4.0 SF15 scores than paediatric patients with chronic health conditions. Child self-report and parent proxy-report showed poor to good agreement. A four-factor model was confirmed among child self-report and parent proxy-report in the confirmatory factor analyses.
Conclusion This study supports the feasibility, reliability and validity of the Iranian version of the PedsQL™ 4.0 SF15 among Iranian children and their parents.

Keywords: children, health-related quality of life, Iran, PedsQL™, short form
Singapore Med J 2013; 54(6): 309-314; http://dx.doi.org/10.11622/smedj.2013123

REFERENCES

1. Amiri P, Ardekani E, Jalali-Farahani S, et al. Reliability and validity of the Iranian version of the Pediatric Quality of Life Inventory™ 4.0 Generic Core Scales in adolescents. Qual Life Res 2010; 19:1501-8.
http://dx.doi.org/10.1007/s11136-010-9712-7
 
2. Jafari P, Ghanizadeh A, Akhondzadeh S, Mohammadi MR. Healthrelated quality of life of Iranian children with attention deficit/hyperactivity disorder. Qual Life Res 2011; 20:31-6.
http://dx.doi.org/10.1007/s11136-010-9722-5
 
3. World Health Organization. Measuring Quality of Life. Geneva: World Health Organization, 1997.
 
4. Higginson IJ, Carr AJ. Measuring quality of life: Using quality of life measures in the clinical setting. BMJ 2001; 322:1297-300.
http://dx.doi.org/10.1136/bmj.322.7297.1297
 
5. Matza LS, Swensen AR, Flood EM, Secnik K, Leidy NK. Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. Value Health 2004; 7:79-92.
http://dx.doi.org/10.1111/j.1524-4733.2004.71273.x
 
6. Solans M, Pane S, Estrada MD, et al. Health-related quality of life measurement in children and adolescents: a systematic review of generic and disease-specific instruments. Value Health 2008; 11:742-64.
http://dx.doi.org/10.1111/j.1524-4733.2007.00293.x
 
7. Varni JW, Limbers CA. The pediatric quality of life inventory: measuring pediatric health-related quality of life from the perspective of children and their parents. Pediatr Clin North Am 2009; 56:843-63.
http://dx.doi.org/10.1016/j.pcl.2009.05.016
 
8. Fayers P, Machin D. Quality of Life: Assessment, Analysis and Interpretation. West Sussex: John Wiley & Sons, 2000.
 
9. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 1999; 37:126-39.
http://dx.doi.org/10.1097/00005650-199902000-00003
 
10. Varni JW, Seid M, Smith Knight T, et al. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. Arthritis Rheum 2002; 46:714-25.
http://dx.doi.org/10.1002/art.10095
 
11. Iannaccone ST, Hynan LS, Morton A, et al. The PedsQL in pediatric patients with spinal muscular atrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscul Disord 2009; 19:805-12.
http://dx.doi.org/10.1016/j.nmd.2009.09.009
 
12. Varni JW, Burwinkle TM, Rapoff MA, Kamps JL, Olson N. The PedsQL in pediatric asthma: reliability and validity of the Pediatric Quality of Life Inventory generic core scales and asthma module. J Behav Med 2004; 27:297-318.
http://dx.doi.org/10.1023/B:JOBM.0000028500.53608.2c
 
13. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer 2002; 94:2090-106.
http://dx.doi.org/10.1002/cncr.10428
 
14. Varni JW, Burwinkle TM, Jacobs JR, et al. The PedsQL in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module. Diabetes Care 2003; 26:631-7.
http://dx.doi.org/10.2337/diacare.26.3.631
 
15. Varni JW, Burwinkle TM, Berrin SJ, et al. The PedsQL in pediatric cerebral palsy: reliability, validity, and sensitivity of the Generic Core Scales and Cerebral Palsy Module. Dev Med Child Neurol 2006; 48:442-9.
http://dx.doi.org/10.1017/S001216220600096X
 
16. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001; 39:800-12.
http://dx.doi.org/10.1097/00005650-200108000-00006
 
17. Gkoltsiou K, Dimitrakaki C, Tzavara C, et al. Measuring health-related quality of life in Greek children: psychometric properties of the Greek version of the Pediatric Quality of Life Inventory(TM) 4.0 Generic Core Scales. Qual Life Res 2008; 17:299-305.
http://dx.doi.org/10.1007/s11136-007-9294-1
 
18. Kook SH, Varni JW. Validation of the Korean version of the pediatric quality of life inventory 4.0 (PedsQL) generic core scales in school children and adolescents using the Rasch model. Health Qual Life Outcomes 2008; 6:41.
http://dx.doi.org/10.1186/1477-7525-6-41
 
19. Uneri OS, Agaoglu B, Coskun A, Memik NC. Validity and reliability of Pediatric Quality of Life Inventory for 2- to 4-year-old and 5- to 7-year-old Turkish children. Qual Life Res 2008; 17:307-15.
http://dx.doi.org/10.1007/s11136-007-9303-4
 
20. Chan KS, Mangione-Smith R, Burwinkle TM, Rosen M, Varni JW. The PedsQL: reliability and validity of the short-form generic core scales and Asthma Module. Med Care 2005; 43:256-65.
http://dx.doi.org/10.1097/00005650-200503000-00008
 
21.Chen X, Origasa H, Ichida F, Kamibeppu K, Varni JW. Reliability and validity of the Pediatric Quality of Life Inventory (PedsQL) Short Form 15 Generic Core Scales in Japan. Qual Life Res 2007; 16:1239-49.
http://dx.doi.org/10.1007/s11136-007-9230-4
 
22. Petersen S, Hägglöf B, Stenlund H, Bergström E. Psychometric properties of the Swedish PedsQL, Pediatric Quality of Life Inventory 4.0 generic core scales. Acta Paediatr 2009; 98:1504-12.
http://dx.doi.org/10.1111/j.1651-2227.2009.01360.x
 
23. Varni JW. PedsQL™ translation methodology [online]. 1998 Available at: http://www.pedsql.org. Accessed May 20, 2013.
 
24. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item ShortForm Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32:40-66.
http://dx.doi.org/10.1097/00005650-199401000-00004
 
25. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995; 4:293-307.
http://dx.doi.org/10.1007/BF01593882
 
26. Nunnally JC, Bernstein IH. Psychometric theory. New York: McGraw-Hill, 1994.
 
27. Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychol Rep 1966; 19:3-11.
http://dx.doi.org/10.2466/pr0.1966.19.1.3
 
28. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1996; 1:30-46.
http://dx.doi.org/10.1037/1082-989X.1.1.30
 
29. Marsh HW, Hau K, Wen Z. In search of golden rules: comment on hypothesis-testing approaches to setting cut-off values for fit indexes and dangers in over generalizing Hu and Bentler's (1999) findings. Structural Equation Modeling 2004; 11:320-41.
http://dx.doi.org/10.1207/s15328007sem1103_2
 
30. Byrne BM. Structural Equation Modeling with AMOS: Basic Concepts, Applications, and Programming. Mahwah, NJ: Lawrence Erlbaum Associates, 1998.
 
31. Hu L, Bentler PM. Cut off criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling 1999; 6:1-55.
http://dx.doi.org/10.1080/10705519909540118
 
32. Browne MW, Cudeck R. Alternative ways of assessing model fit. Sociol Methods Res 1992; 21:230-58.
http://dx.doi.org/10.1177/0049124192021002005
 
33. Sivo SA, Fan X, Witta EL, Willse JT. The search for "optimal" cutoff properties: fit index criteria in structural equation modeling. J Exp Educ 2006; 74:267-88.
http://dx.doi.org/10.3200/JEXE.74.3.267-288
 
34. Enders CK, Bandalos DL. The relative performance of full information maximum likelihood estimation for missing data in structural equation models. Struct Equ Modeling 2001; 8:430-57.
http://dx.doi.org/10.1207/S15328007SEM0803_5
 
35. Michel G, Bisegger C, Fuhr DC, Abel T, KIDSCREEN Group. Age and gender differences in health-related quality of life of children and adolescents in Europe: a multilevel analysis. Qual Life Res 2009; 18:1147-57.
http://dx.doi.org/10.1007/s11136-009-9538-3
 
36. Simeoni MC, Auquier P, Antoniotti S, Sapin C, San Marco JL. Validation of a French health-related quality of life instrument for adolescents: the VSP-A. Qual Life Res 2000; 9:393-403.
http://dx.doi.org/10.1023/A:1008957104322
 
37. Limbers CA, Newman DA, Varni JW. Factorial invariance of child selfreport across age subgroups: a confirmatory factor analysis of ages 5 to 16 years utilizing the PedsQL 4.0 Generic Core Scales. Value Health 2008; 11:659-68.
http://dx.doi.org/10.1111/j.1524-4733.2007.00289.x
 
38. Mortazavi SH, Karimi E. Cultural Dimensions of Paternalistic Behavior – A Cross-Cultural Research in Five Countries. In: Iwawaki S, Kashima Y, Leung K, eds. Innovations in Cross-Cultural Psychology. Amsterdam: Garland Science, 1992: 147-51.
 
39. Tamadonfar M. Islam, law, and political control in contemporary Iran. J Sci Study Relig 2001; 40:205-20.
http://dx.doi.org/10.1111/0021-8294.00051

Feasibility of a novel two-piece nasogastric feeding tube for patients with dysphagia

Share this Article

Singapore Med J 2013; 54: 227-230; http://dx.doi.org/10.11622/smedj.2013079
Feasibility of a novel two-piece nasogastric feeding tube for patients with dysphagia

Liu SY, Yang CP, Wei TS, Chen YC, Liang CH, Wu CH, Chen CL, Wu JJ
Correspondence: Dr Tsung-Ju Wu, liusenyong111@yeah.net

ABSTRACT
Introduction The exposed section of a traditional nasogastric (NG) tube can interfere with patients’ social activities and thereby result in distress. This study was conducted to evaluate the feasibility and safety of a novel two-piece NG tube for patients with dysphagia.
Methods Ten patients with dysphagia were recruited between November 2011 and May 2012. Patients who were unconscious or in critical condition, had a traditional NG tube < 50 cm or > 60 cm in fixed length, or were unable to follow instructions or sign consent forms were excluded. The two-piece NG tube, which was placed in the patients for one week, comprised a removable external tube that can be joined to an internal tube via a T-connector, which was placed close to the naris. Events related to safety (e.g. nasal pressure sores, number of unplanned extubation, displacement and spontaneous migration of the NG tube, other unpredictable injuries) and effectiveness (e.g. liquid food spills, tube obstruction, perfusion rate, other adverse circumstances) were assessed daily.
Results All patients received feeding without complication using the two-piece NG tube and none experienced premature removal of the tube. No serious NG tube complications or malfunctions were observed.
Conclusion The results of this study indicate that the two-piece NG feeding tube is a feasible option for patients with dysphagia. Future improvements to the connector may help enhance its performance. A rigorous randomised controlled trial to examine the effects of the two-piece NG tube on patients’ quality of life and quality of medical care is being planned.

Keywords: dysphagia, feeding tube, nasogastric, quality of life, rehabilitation
Singapore Med J 2013; 54: 227-230; http://dx.doi.org/10.11622/smedj.2013079

REFERENCES

1. Stroud M, Duncan H, Nightingale J. Guidelines for enteral feeding in adult hospital patients. Gut 2003; 52(Suppl 7):vii1-vii12.
http://dx.doi.org/10.1136/gut.52.suppl_7.vii1
 
2. Wade DT. Measuring arm impairment and disability after stroke. Int Disabil Stud 1989; 11:89-92.
http://dx.doi.org/10.3109/03790798909166398
 
3. Huang NC, Wei TS, Liu SY. The influence of nasogastric tube to post-stroke depressive tendency and functional outcome. Taiwan J Phys Med Rehabil 2006; 34:19-26.
 
4. Carrión MI, Ayuso D, Marcos M, et al. Accidental removal of endotracheal and nasogastric tubes and intravascular catheters. Crit Care Med 2000; 28:63-6.
http://dx.doi.org/10.1097/00003246-200001000-00010
 
5. Neumann MJ, Meyer CT, Dutton JL, Smith R. Hold that x-ray: aspirate pH and auscultation prove enteral tube placement. J Clin Gastroenterol 1995; 20:293-5.
http://dx.doi.org/10.1097/00004836-199506000-00007
 
6. Burns SM, Martin M, Robbins V, et al. Comparison of nasogastric tube securing methods and tube types in medical intensive care patients. Am J Crit Care 1995; 4:198-203.
 
7. Maccioli GA, Dorman T, Brown BR, et al. Clinical practice guidelines for the maintenance of patient physical safety in the intensive care unit: use of restraining therapies--American College of Critical Care Medicine Task Force 2001-2002. Crit Care Med 2003; 31:2665-76.
http://dx.doi.org/10.1097/01.CCM.0000095463.72353.AD
 
8. Dornan T, O'Neill P. Core Clinical Skills for OSCEs in Medicine. 2nd ed. Edinburgh: Churchill Livingstone, 2006:241-2.
 
9. Price B. Making sense of nasogastric intubation. Nurs Times 1989; 85:50-2.
 
10. Zhao YH. Methods of increasing the successful rate of one-time nasogastric tube placement and improving the effectiveness of drainage. Nurs Pract Res 2009; 16:1-2.
 
11. Beckstrand J, Cirgin Ellett ML, McDaniel A. Predicting internal distance to the stomach for positioning nasogastric and orogastric feeding tubes in children. J Adv Nurs 2007; 59:274-89.
http://dx.doi.org/10.1111/j.1365-2648.2007.04296.x
PMid:17590213
 
12. Metheny NA. Titler MG. Assessing placement of feeding tubes. Am J Nurs 2001; 101:36-45.
http://dx.doi.org/10.1097/00000446-200105000-00017
 
13. Yamada T. Textbook of Gastroenterology. 4th ed. Philadelphia: Lippincott Williams & Wilkins 2003: 1062-3.
 
14. Norton B, Homer-Ward M, Donnelly MT, Long RG, Holmes GK. A randomised prospective comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding after acute dysphagic stroke. BMJ 1996; 312:13-6.
http://dx.doi.org/10.1136/bmj.312.7022.13
 
15. Bannerman E, Pendlebury J, Phillips F, Ghosh S. A cross-sectional and longitudinal study of health-related quality of life after percutaneous gastrostomy. Eur J Gastroenterol Hepatol 2000; 12:1101-9.
http://dx.doi.org/10.1097/00042737-200012100-00006
 
16. Lin LC, Li MH, Watson R. A survey of the reasons patients do not chose percutaneous endoscopic gastrostomy/jejunostomy (PEG/PEJ) as a route for long-term feeding. J Clin Nurs 2011; 20:802-10.
http://dx.doi.org/10.1111/j.1365-2702.2010.03541.x
 
17. Metheny NA, Clouse RE, Chang YH, et al. Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: frequency, outcomes, and risk factors. Crit Care Med 2006; 34:1007-15.
http://dx.doi.org/10.1097/01.CCM.0000206106.65220.59
 
18. Ho MM, Hor YS, Li SC, et al. The exploration of home care patients' unplanned extubation and the primary caregivers' knowledge, and learning needs related to tubing care. J Long-term Care 2008; 12:72-90.

Paediatric inflammatory bowel disease in a multiracial Asian country

Share this Article

Singapore Med J 2013; 54: 201-205; http://dx.doi.org/10.11622/smedj.2013073
Paediatric inflammatory bowel disease in a multiracial Asian country

Chu HP, Logarajah V, Tan N, Phua KB
Correspondence: Dr Chu Hui Ping, chu_huiping@rafflesmedical.com

ABSTRACT
Introduction This study examined the characteristics and trends in the incidence of inflammatory bowel disease (IBD) among children in Singapore.
Methods We retrospectively reviewed all patients under 18 years diagnosed with IBD over a 14-year period. Information on demographics, disease presentation, laboratory findings, radiological investigations, and endoscopic and histological findings were obtained from the patients’ medical records.
Results 32 patients were diagnosed with IBD, 30 of whom had Crohn’s disease and 2 had ulcerative colitis. The incidence of IBD rose from an initial rate of 2.2 per 100,000 patients in the year 2000 to a peak of 11.4 patients per 100,000 patients by 2008. Median age of onset of symptoms was 10.5 years. There were more boys (63%) than girls in the group and a higher representation of Indians (34.4%). The most common presenting symptoms were abdominal pain (87.5%), diarrhoea (75.0%) and weight loss (71.9%). Extraintestinal manifestations such as fever and arthralgia were found in over 50% of patients. The most common physical findings were perianal abnormalities (56.3%), mouth ulcers (37.5%) and growth failure (15.6%). Abnormal laboratory findings such as low albumin, raised erythrocyte sedimentation rate, anaemia, thrombocytosis and high C-reactive protein were found in nearly half of the patients. Endoscopic and histological findings showed that a majority of patients (90.6%) also had evidence of inflammation in the upper gastrointestinal tract.
Conclusion Paediatric IBD is on the rise. The higher occurrence in Indians, earlier onset and more florid presentation may suggest different genetic and environmental influences specific to Asian children.

Keywords: Asian races, Crohn’s disease, paediatric IBD, ulcerative colitis
Singapore Med J 2013; 54: 201-205; http://dx.doi.org/10.11622/smedj.2013073

REFERENCES

1. Tan CC, Kang JY, Guan R, Yap I, Tay HH. Inflammatory bowel disease: an uncommon problem in Singapore. J Gastroenterol Hepatol 1992; 7:360-2.
http://dx.doi.org/10.1111/j.1440-1746.1992.tb00997.x
 
2. Thein-Htut, Kudva MV. Ulcerative colitis in Malaysians: a review of 23 patients. Singapore Med J 1989; 30:385-7.
 
3. Probert CS, Mayberry JF, Mann R. Inflammatory bowel disease in the rural Indian subcontinent: a survey of patients attending mission hospitals. Digestion 1990; 47:42-6.
http://dx.doi.org/10.1159/000200475
 
4. Sood A, Midha V. Epidemiology of inflammatory bowel disease in Asia. Indian J Gastroenterol 2007; 26:285-9.
 
5. Lakatos PL. Recent trends in the epidemiology of inflammatory bowel disease: up or down? World J Gastroenterol 2006 14; 12:6102-8.
 
6. Kitahora T, Utsunomiya T, Yokota A. Epidemiological study of ulcerative colitis in Japan: incidence and familial occurrence: The Epidemiology Group of the Research Committee of Inflammatory Bowel disease in Japan. J Gastroenterol 1995; 30:5-8.
 
7. Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008; 103:3167-82.
http://dx.doi.org/10.1111/j.1572-0241.2008.02158.x
 
8. Beattie M. Inflammatory bowel disease: introduction. In: Beattie M, Dhawan A, Puntis JWL. Paediatric gastroenterology, hepatology, and nutrition. New York: Oxford University Press, 2009:287-90.
http://dx.doi.org/10.1093/med/9780198569862.003.0041
 
9. Mamula P, Markowitz JE, Baldassano RN. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am 2003; 32:967-95.
http://dx.doi.org/10.1016/S0889-8553(03)00046-3
 
10. Motil KJ, Grand RJ, Davis-Kraft L, Ferlic LL, Smith EO. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology 1993; 105:681-91.
 
11. Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 2003; 88:995-1000.
http://dx.doi.org/10.1136/adc.88.11.995
 
12. Sun L, Roesler J, Rosen-Wolff A, et al. CARD15 genotype and phenotype analysis in 55 paediatric patients with Crohn disease from Saxony, Germany. J Pediatr Gastroenterol Nutr 2003; 37:492-7.
http://dx.doi.org/10.1097/00005176-200310000-00017
 
13. Sanchez R, Levy E, Costea F, Sinnett D. IL-10 and TNF promoter haplotypes are associated with childhood Crohn's disease location. World J Gastrenterol 2009; 15:3776-82.
http://dx.doi.org/10.3748/wjg.15.3776
 
14. Singapore Economic Development Board. Singapore Facts & Figures [online]. http://www.edbsingapore.jp/edb/sg/en_uk/index/why_singapore/singapore_fa.... Accessed February 28, 2013.
 
15. Lee YM, Fock K, See SJ, et al. Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore. J Gastroenterol Hepatol 2000; 15:622-5.
http://dx.doi.org/10.1046/j.1440-1746.2000.02212.x
 
16. Barton JR, Gillon S, Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. Gut 1989; 30:618-22.
http://dx.doi.org/10.1136/gut.30.5.618
 
17. Hildebrand H, Finkel Y, Grahnquist L, et al. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001. Gut 2003; 52:1432-4.
http://dx.doi.org/10.1136/gut.52.10.1432
 
18. Sawczenko A, Sandhu BK, Logan RF, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001; 357:1093-4.
http://dx.doi.org/10.1016/S0140-6736(00)04309-9
 
19. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 2003; 143:525-31.
http://dx.doi.org/10.1067/S0022-3476(03)00444-X
 
20. Ishige T, Tomomasa T, Takebayashi T, et al. Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan. J Gastroenterol 2010; 45:911-7.
http://dx.doi.org/10.1007/s00535-010-0223-7
 
21. Avinash B, Dutta AK, Chacko A. Pediatric inflammatory bowel disease in South India. Indian Pediatr 2009; 46:639-40.
 
22. Hsiao CH, Wei SC, Wong JM, et al. Pediatric Crohn disease: clinical and genetic characteristics in Taiwan. J Pediatr Gastroenterol Nutr 2007; 44:342-6.
http://dx.doi.org/10.1097/MPG.0b013e31802c6997
 
23. Tan A, Wee A, Quak SH. Chronic inflammatory bowel disease in Singapore children. J Singapore Paediatr Soc 1992; 34:209-13.
 
24. IBD working group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis – the Porto criteria. J Pediatr Gastroenterol Nutr 2005; 41:1-7.
http://dx.doi.org/10.1097/01.MPG.0000163736.30261.82
 
25.UK IBD working group on behalf of the British Society of Paediatric Gastroenterology Hepatology and Nutrition (BSPGHAN). Guidelines for the management of inflammatory bowel disease (IBD) in children in the United Kingdom. In: British Society of Paediatric Gastroenterology Hepatology and Nutrition [online]. Available at: www.bspghan.org.uk/working_groups/documents/IBDGuidelines_000.pdf. Accessed October 19, 2010.
26. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 2008; 14:542-9.
http://dx.doi.org/10.1002/ibd.20310
 
27. Jiang L, Xia B, Li J, et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis 2006; 12:212-7.
http://dx.doi.org/10.1097/01.MIB.0000201098.26450.ae
 
28. Weinstein TA, Levine M, Pettei MJ, et al. Age and family history at presentation of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2003; 37:609-13.
http://dx.doi.org/10.1097/00005176-200311000-00020
 
29. Tan YM, Goh KL. Ulcerative colitis in a multiracial Asian country: racial differences and clinical presentation among Malaysian patients. World J Gastroenterol 2005; 11:5859-62.
 
30. Lindberg E, Lindquist B, Holmquist L, Hildebrand H. Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. J Pediatr Gastroenterol Nutr 2000; 30:259-64.
http://dx.doi.org/10.1097/00005176-200003000-00009
 
31. Abramson O, Durant M, Mow W, et al. Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. J Pediatr 2010; 157:233-9.
http://dx.doi.org/10.1016/j.jpeds.2010.02.024
 
32. Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations in inflammatory bowel disease. Gastroenterol Clin North Am 2002; 31:307-27.
http://dx.doi.org/10.1016/S0889-8553(01)00019-X
 
33. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996; 23:29-34.
http://dx.doi.org/10.1097/00004836-199607000-00009
 
34. Castellaneta SP, Afzal NA, Greenberg M, et al. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2004; 39:257-61.
http://dx.doi.org/10.1097/00005176-200409000-00006
 
35. Abdullah BA, Gupta SK, Croffie JM, et al. The role of esophagogastroduodenoscopy in the initial evaluation of childhood inflammatory bowel disease: a 7-year study. J Pediatr Gastroenterol Nutr 2002; 35:636-40.
http://dx.doi.org/10.1097/00005176-200211000-00009
 
36. Fock KM. Helicobacter pylori infection – current status in Singapore. Ann Acad Med Singapore 1997; 26:637-41.
 
37. Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis 2010; 16:1077-84.
http://dx.doi.org/10.1002/ibd.21116

The modified Medical Research Council dyspnoea scale is a good indicator of health-related quality of life in patients with chronic obstructive pulmonary disease

Share this Article

Singapore Med J 2013; 54(6): 321-327; http://dx.doi.org/10.11622/smedj.2013125
The modified Medical Research Council dyspnoea scale is a good indicator of health-related quality of life in patients with chronic obstructive pulmonary disease

Hsu KY, Lin JR, Lin MS, Chen W, Chen YJ, Yan YH
Correspondence: Dr Jr-Rung Lin, jr@mail.cgu.edu.tw

ABSTRACT
Introduction Health-related quality of life (HRQoL) is an important patient-centred outcome in chronic obstructive pulmonary disease (COPD). The aim of the current study is to compare the discriminative capacity of the modified Medical Research Council (mMRC) dyspnoea scale and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) spirometric classification of COPD on HRQoL, as well as determine other factors that are simple and determinative of HRQoL.
Methods In this cross-sectional observational study, a total of 328 patients with COPD were enrolled from the pulmonology outpatient clinic. HRQoL was measured using the St George’s Respiratory Questionnaire (SGRQ) and the World Health Organization Quality of Life-BREF (WHOQOL-BREF). HRQoL scores were compared between the four GOLD stages and the five grades of the mMRC scale. Significant differences were determined using analysis of variance with Scheffe post-hoc test. Multiple linear regression was applied to explore the major determinants of HRQoL and exclude confounding factors.
Results Signi?cant differences were found in many more domains of the two questionnaires between mMRC grades than between GOLD stages. In the multiple linear regression model, the mMRC scale was the only factor that remained determinative of all the domains of SGRQ and WHOQOL-BREF. Patients with chronic productive cough, sleep disorders and frequent exacerbations had poorer HRQoL, as reflected by higher scores in SGRQ or lower scores in WHOQOL-BREF.
Conclusion The mMRC dyspnoea scale is a concise and practical tool to assess the HRQoL of patients with COPD in daily clinical practice.

Keywords: chronic obstructive pulmonary disease, Global Initiative for Chronic Obstructive Lung Disease, health-related quality of life, Medical Research Council dyspnoea scale, spirometry
Singapore Med J 2013; 54(6): 321-327; http://dx.doi.org/10.11622/smedj.2013125

REFERENCES

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2010). Available at: http://www.goldcopd.org/uploads/users/files/GOLDReport_April112011.pdf. Accessed: August 31, 2011.
 
2. Marin JM, Cote CG, Diaz O, et al. Prognostic assessment in COPD: Health related quality of life and the BODE index. Respir Med 2011; 105:916-21.
http://dx.doi.org/10.1016/j.rmed.2011.01.007
 
3. Jones PW, Brusselle G, Dal Negro RW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 2011; 105:57-66.
http://dx.doi.org/10.1016/j.rmed.2010.09.004
 
4. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356:775-89.
http://dx.doi.org/10.1056/NEJMoa063070
 
5. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359:1543-54.
http://dx.doi.org/10.1056/NEJMoa0805800
 
6. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059-73.
http://dx.doi.org/10.1056/NEJMoa030287
 
7. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995; 122:823-32.
http://dx.doi.org/10.7326/0003-4819-122-11-199506010-00003
 
8. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:680-5.
http://dx.doi.org/10.1164/rccm.2112043
 
9. Fan VS, Curtis JR, Tu SP, McDonell MB, Fihn SD. Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest 2002; 122:429-36.
http://dx.doi.org/10.1378/chest.122.2.429
 
10. Engstrom CP, Persson LO, Larsson S, Sullivan M. Health-related quality of life in COPD: why both disease-specific and generic measures should be used. Eur Respir J 2001; 18:69-76.
http://dx.doi.org/10.1183/09031936.01.00044901
 
11. Antonelli-Incalzi R, Imperiale C, Bellia V, et al. Do GOLD stages of COPD severity really correspond to differences in health status? Eur Respir J 2003; 22:444-9.
http://dx.doi.org/10.1183/09031936.03.00101203
 
12. Hajiro T,Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999; 116:1632-7.
http://dx.doi.org/10.1378/chest.116.6.1632
 
13. Medinas Amoros M, Mas-Tous C, Renom-Sotorra F, et al. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index. Chron Respir Dis 2009; 6:75-80.
http://dx.doi.org/10.1177/1479972308101551
 
14. Mahler DA, Wells CK. Evaluation of clinical methodsfor rating dyspnea. Chest 1988; 93:580-6.
http://dx.doi.org/10.1378/chest.93.3.580
 
15. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54:581-6.
http://dx.doi.org/10.1136/thx.54.7.581
 
16. Oga T, Nishimura K, Tsukino M, et al. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med 2007; 101:146-53.
http://dx.doi.org/10.1016/j.rmed.2006.04.001
 
17. Mannino DM, ThornD, SwensenA,Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32:962-9.
http://dx.doi.org/10.1183/09031936.00012408
 
18. Nizet TA, van den Elshout FJ, Heijdra YF, et al. Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity,and hypoxemia. Chest 2005; 127:1904-10.
http://dx.doi.org/10.1378/chest.127.6.1904
 
19. Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 2010; 182:325-31.
http://dx.doi.org/10.1164/rccm.200912-1869OC
 
20.Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319-38.
http://dx.doi.org/10.1183/09031936.05.00034805
 
21. Berglund E,BirathG,Bjure J, et al. Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand 1963; 173:185-92.
http://dx.doi.org/10.1111/j.0954-6820.1963.tb16520.x
 
22. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145:1321-7.
http://dx.doi.org/10.1164/ajrccm/145.6.1321
 
23. Wang KY, Chiang CH, Maa SH, Shau WY, Tarn YH. Psychometric assessment of the Chinese language version of the St. George's Respiratory Questionnaire in Taiwanese patients with bronchial asthma. J Formos Med Assoc 2001; 100:455-60.
 
24. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med. 1998; 46:1569-85.
 
25. Yao G, Chung CW, Yu CF, Wang JD. Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J Formos Med Assoc 2002;101:342-51.
 
26. Agusti A. Thomas a. Nefflecture. Chronic obstructive pulmonary disease: a systemic disease. Proc Am Thorac Soc 2006; 3:478-81.
http://dx.doi.org/10.1513/pats.200603-058MS
 
27. Papaioannou AI, Loukides S, Gourgoulianis KI, Kostikas K. Global assessment of the COPD patient: time to look beyond FEV1? Respir Med 2009; 103:650-60.
http://dx.doi.org/10.1016/j.rmed.2009.01.001
 
28. Jenkins C, Rodriguez-Roisin R. Quality of life, stage severity and COPD. Eur Respir J 2009; 33:953-5.
http://dx.doi.org/10.1183/09031936.00019009
 
29. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959; 2:257-66.
http://dx.doi.org/10.1136/bmj.2.5147.257
 
30. Jones R, Ostrem A. Optimising pharmacological maintenance treatment for COPD in primary care. Prim Care Respir J 2011; 20:33-45.
http://dx.doi.org/10.4104/pcrj.2010.00069
 
31. Bridevaux PO, Gerbase MW, Probst-Hensch NM, et al. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008; 63:768-74.
http://dx.doi.org/10.1136/thx.2007.093724
 
32. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1418-22.
http://dx.doi.org/10.1164/ajrccm.157.5.9709032
 
33. Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004; 23:698-702.
http://dx.doi.org/10.1183/09031936.04.00121404
 
34. Rutgers SR, ten Hacken NH, Koeter GH, Postma DS. Borg scores before and after challenge with adenosine 5'-monophosphate and methacholine in subjects with COPD and asthma. Eur Respir J 2000; 16:486-90.
http://dx.doi.org/10.1034/j.1399-3003.2000.016003486.x
 
35. Jones RC, Donaldson GC, Chavannes NH, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med 2009; 180:1189-95.
http://dx.doi.org/10.1164/rccm.200902-0271OC
 
36. Annual report of tobacco, alcohol consumption investigation in Taiwan area. Taipei, Taiwan: Bureau of Tobacco and Alcohol Monopoly, Taiwan Provincial Government, 1993.

Immune response in infants after universal hepatitis B vaccination: a community-based study in Malaysia

Share this Article

Singapore Med J 2013; 54: 224-226; http://dx.doi.org/10.11622/smedj.2013078
Immune response in infants after universal hepatitis B vaccination: a community-based study in Malaysia

Cheang HK, Wong HT, Ho SC, Chew KS, Lee WS
Prof Way Seah Lee, leews@um.edu.my

ABSTRACT
Introduction This study aimed to assess the immune response in infants who received the three-shot hepatitis B vaccine in Malaysia.
Methods Consecutive infants born between March 2002 and April 2010 who received three doses of hepatitis B vaccine at a community clinic in Malaysia were enrolled in the study. Screening for hepatitis B surface antigen (HBsAg) and antibody against HBsAg (anti-HBs) was performed after the completion of primary immunisation, at approximately one year of age.
Results A total of 572 infants (median age 9.3 ± 2.7 months; range 6.3–48 months) were screened for immune response to hepatitis B vaccination – 553 (96.7%) infants had adequate levels of anti-HBs (≥ 10 IU/L). Of the 440 mothers whose HBsAg status was known, 14 (3.2%) were positive for HBsAg. None of the 14 infants who were born to HBsAg-positive mothers were positive for HBsAg, and all but one infant had anti-HBs level ≥ 10 IU/L. Gender, gestational age and maternal HBsAg status were not found to significantly affect the subsequent immune response in infants following vaccination.
Conclusion The proportion of Malaysian mothers who are positive for HBsAg remains high. The three-shot hepatitis B vaccine, given as part of universal vaccination against hepatitis B, provides adequate anti-HBs in the vast majority of infants in a community setting in Malaysia.


Keywords:community, hepatitis B vaccination, immune response
Singapore Med J 2013; 54: 224-226; http://dx.doi.org/10.11622/smedj.2013078
REFERENCES
1. Huang LM, Lu CY, Chen DS. Hepatitis B virus infection, its sequelae, and prevention by vaccination. Curr Opin Immunol 2011; 23:237-43.
http://dx.doi.org/10.1016/j.coi.2010.12.013
 
2. World Health Organization. Immunization, vaccines and biologicals [online]. Available at: http://www.who.int/immunization/topics/hepatitis_b/en/index.html. Accessed September 1, 2011.
3. Shih HH, Chang MH, Hsu HY, et al. Long term immune response of universal hepatitis B vaccination in infancy: a community-based study in Taiwan. Pediatr Infect Dis J 1999; 18:427-32.
http://dx.doi.org/10.1097/00006454-199905000-00006
 
4. Rosado MM, Scarsella M, Pandolfi E, et al. Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example. Eur J Immunol 2011; 41:1800-8.
http://dx.doi.org/10.1002/eji.201041187
 
5. Wong SL, Soosai P, Teoh YL, et al. Four is better than nine: a combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenza type b vaccine for routine immunization in Malaysia. Southeast Asian J Trop Med Public Health 2008; 39:474-83.
 
6. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody level is protective? J Infect Dis 1999; 179:489-92.
http://dx.doi.org/10.1086/314578
 
7. McMahon BJ, Bulkow LR, Singleton RJ, et al. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology 2011; 54:801-7.
http://dx.doi.org/10.1002/hep.24442
 
8. Chen HL, Chang CJ, Kong MS, et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 2004; 39:58-63.
http://dx.doi.org/10.1002/hep.20006
 
9. Liao MT, Chang MH, Lin FG, et al. Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy. Pediatrics 2011; 128:e600-4.
 
10. Ng KP, Saw TL, Baki A, et al. Impact of the expanded program of immunization against hepatitis B infection in school children in Malaysia. Med Microbiol Immunol 2005; 194:163-8.
http://dx.doi.org/10.1007/s00430-004-0231-4
 
11. Jafarzadeh A, Zarei S, Shokri F. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy nonresponder neonates. Vaccine 2008; 26:269-76.
http://dx.doi.org/10.1016/j.vaccine.2007.10.044
 
12. Chen HL, Lin LH, Hu FC, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 2012; 142:773-781.e2